Human Islet Research Network
Menu

NIH Announcements

    • HIRN Requests for Applications (RFAs):
      • RFA-DK-17-021: Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
        NIDDK intends to commit up to $3.5 million to fund 4-6 awards in FY 2018.
        Letter of Intent due: April 10, 2018
        Application due: May 10, 2018

      • RFA-DK-17-022: High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed)
        NIDDK intends to commit up to $4 million to fund 4-6 awards in FY 2018.
        Letter of Intent due: April 10, 2018
        Application due: May 10, 2018

    • Additional NIH Requests for Applications (RFAs):

      • RFA-RM-18-011: Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
        The NIH Common Fund intends to commit $2M to fund 5-6 awards in FY 2019.
        Letter of Intent due: June 9, 2018
        Application due: July 9, 2019

      • RFA-DK-18-005: Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
        NIDDK intends to commit $3.25 million in FY 2019 to fund 4-5 awards.
        Letter of Intent due: November 6, 2018
        Application due: December 6, 2018
      • RFA-DK-17-031The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
        NIDDK intends to commit up to $1.25 million to fund 2-3 awards in FY 2018 and up to $1.25 million to fund 2-3 awards in FY 2019.
        Letter of Intent due: March 26, 2018 and November 6, 2018
        Application due: April 26, 2018 and December 6, 2018

      • RFA-DK-18-003: Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status in People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
        NIDDK intends to commit up to $1.9 million to fund 2 awards in FY 2018.
        Letter of Intent due: June 10, 2018
        Application due: July 10, 2018

        Click here to view all NIH NIDDK Special Diabetes Program Funding Opportunities.